Fieve Rr
About
In The Last Decade
Fieve Rr
30 papers receiving 393 citations
Peers
Comparison fields: 5 of 71
- Psychiatry and Mental health 255
- Pharmacology 157
- Clinical Psychology 74
- Experimental and Cognitive Psychology 69
- Cellular and Molecular Neuroscience 50
Countries citing papers authored by Fieve Rr
This map shows the geographic impact of Fieve Rr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fieve Rr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fieve Rr more than expected).
Fields of papers citing papers by Fieve Rr
This network shows the impact of papers produced by Fieve Rr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fieve Rr. The network helps show where Fieve Rr may publish in the future.
Co-authorship network of co-authors of Fieve Rr
This figure shows the co-authorship network connecting the top 25 collaborators of Fieve Rr. A scholar is included among the top collaborators of Fieve Rr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fieve Rr. Fieve Rr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo. | 31 |
| 2 | Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGI change. | 9 |
| 3 | Maintenance treatment of unipolar depression. | 3 |
| 4 | Bipolar II--a distinct diagnostic entity? | 2 |
| 5 | Platelet monoamine oxidase activity in affective disorder. | 12 |
| 6 | Psychopathology among children of manic-depressive patients. | 28 |
| 7 | Affective episode frquency and lithium therapy. | 5 |
| 8 | The lithium clinic for treatment and prevention of manic depression: a cost benefit approach. | 1 |
| 9 | Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. | 89 |
| 10 | Prostaglandin F in patients with primary affective disorder. | 9 |
| 11 | Erythrocyte catechol-o-methyltransferase activity in primary affective disorder. | 22 |
| 12 | L-tryptophan in depression. | 25 |
| 13 | Linkage studies in affective disorders: the Xg blood group and manic-depressive illness. | 22 |
| 14 | A dominant X-linked factor in manic-depressive illness: studies with color blindness. | 5 |
| 15 | Affective disease health maintenance organization. Patterns of lithium response. | 2 |
| 16 | Proceedings: Rubidium salts--toxic effects in humans and clinical effects as an antidepressant drug. | 4 |
| 17 | Lithium in psychiatry: reply to discussants. | 1 |
| 18 | Lithium for manic depressive disorders, challenge to electroshock therapy? | 4 |
| 19 | Lithium in psychiatry. | 5 |
| 20 | Lithium and thyroid function. Reply. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.